HANOI: Việt Nam Pharmacy Corporation (VinaPharm) will sell more than 42 million shares in its initial public offering, with a starting price of VNĐ10,000 each on the Hà Nội Stock Exchange (HNX). Under the equitisation plan, the IPO shares represent nearly 18 per cent of the stake, the Ministry of Health on behalf of the State will hold 65 per cent of the stake, while a strategic investor will hold about 17 per cent.
According to Vinapharm, its strategic investor will be a local investor with a minimum of 10 years experience in the medical field. The investor must have a minimum charter capital of VNĐ800 million, accumulated in three years from 2012 to 2014. Based in Hà Nội, VinaPharm will then have a charter capital of VNĐ2.37 trillion. VinaPharm has currently invested in big pharmaceutical companies such as Imexpharm, MPK, OPC and Vidipha, in addition to Vimedimex and Phytopharma. It also owns several plots in prime locations in Hà Nội and HCM City.
